mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |